Pfizer Inc Company Profile, Facts | Competitive Intelligence Report – Market.us

Pune, Maharashtra, India, September 21 2022 (Wiredrelease) Prudour Pvt. Ltd –:Pfizer Inc. is a pharmaceutical powerhouse that has been in operation for over 150 years. The company has developed and manufactured some of the world’s most innovative and life-saving drugs. Pfizer’s products are available in over 150 countries, making it a truly global player in the pharmaceutical industry. Pfizer’s products touch the lives of millions of people around the world, and the company is committed to improving the lives of its patients through its innovative products and services. Pfizer Inc. is a global leader in the pharmaceutical industry, and its products have helped improve the lives of millions of people around the world. Its products include Lipitor (atorvastatin), Viagra (sildenafil), Celebrex (celecoxib), Lyrica (pregabalin), and Zoloft (sertraline). 

It offers contract manufacturing services, sterile injection pharmaceuticals, biosimilars, active pharma ingredients (APIs), and sterile injectable pharmaceuticals. Pfizer sells its products via wholesalers and retailers, hospitals, clinics as well as government agencies, pharmacies, and clinics. It has manufacturing facilities in India and China as well as Germany, Singapore, Singapore, Italy, Belgium and Germany. It sells its products in North America and South America, Asia-Pacific as well as Australia, Europe, Africa, and the Middle East. Pfizer’s headquarters are located in New York, USA.

Financial Overview

The company has a strong financial position, with revenues of $52.5 billion in 2016 and $48.8 billion in 2017. The net income was $10.4 billion in 2016 and $12.6 billion in 2017. The total assets were $191 billion in 2016 and $205 billion in 2017. The total equity was $70 billion in 2016 and $79 billion in 2017. Pfizer Inc.’s stock price has been on a gradual uptrend over the past five years, from around $20 per share in 2013 to its current level of around $36 per share.

Place a Direct Order Of Pfizer Inc Company Profile @ https://market.us/purchase-company/?company_id=80035

Key Financials
Revenue (US$Mn)

– Pfizer Inc. generated US$ 81 288 Mn in annual revenue in 2021

– Pfizer Inc.’s 2020 annual revenue was US$ 41.908 Mn. This is a decrease of -19.02% from 2019.

– Pfizer Inc reported a -3.54% decline in annual revenue from 2018 to 2019, which amounts to US$ 51.750 Mn

– Pfizer Inc. generated total revenue of US$ 53 647 Mn in 2018.

Browse Full Summary of Pfizer Inc Company Profile@ https://market.us/company/pfizer-inc/

Operating Income (US$Mn)

– Pfizer Inc.’s operating income in 2021 was US$ 22,235 Mn. This is a 130.99% rise over 2020.

– Pfizer Inc’s 2020 operating income was US$ 8,760 Million

– Pfizer Inc’s operating profit of US$ 13,921Mn, which was down -7.47%, was indexed in 2019.

– Pfizer Inc had an operating income in 2018 of US$ 15,045 Million

Recent developments/news

Pfizer Inc has been in the news recently for its involvement in the development of a coronavirus vaccine. The company is working with German biotech firm BioNTech to develop the vaccine. Clinical trials of the vaccine are currently underway. If the vaccine is successful, it could be available for use by the end of 2020. Pfizer Inc is also working on developing other potential treatments for coronavirus, including an antiviral drug and a monoclonal antibody treatment. 

Explore More Company Profiles:

General Dynamics Corporation Company Profile Report: https://market.us/company/general-dynamics-corporation/

Northrop Grumman Corporation Company Profile Strategic Moves, and Competitive Intelligence Report – Market.us: https://market.us/company/northrop-grumman-corporation/

Thales S.A. Company Profile and News – Market.us: https://market.us/company/thales-s-a/

This content has been published by Prudour Pvt. Ltd company. The WiredRelease News Department was not involved in the creation of this content. For press release service enquiry, please reach us at contact@wiredrelease.com.